This clinical-stage biotech targets chronic pruritus and cough with its lead therapy for neurologically mediated diseases.

For adults with a history of depression, chronic cough can increase the risk of recurrent depressive events, a study found. Adults with chronic cough experience a disproportionate burden of depressive ...

Chronic cough, with symptoms lasting more than eight weeks, affects approximately one in 10 adults. Cough is among the most common reasons for seeking medical care in the United States, yet chronic ...

Please provide your email address to receive an email when new articles are posted on . Poor lung function trajectories were found among those with chronic productive cough and those with intermittent ...

Chronic cough took center stage at the European Respiratory Society (ERS) Congress session titled "Conditions We Are Just Dealing With the Tip of the Iceberg in Primary Care: Frequently Mismanaged ...

Recurrent chronic cough has no FDA-approved treatments, but efforts are underway to bring one to the market. GSK sees a late-stage drug candidate from Bellus Health as potentially best in class and ...

Acquiring Bellus Health gives GSK a drug for recurrent chronic cough that could offer a better side effect profile compared to a Merck drug that addresses the same target. Bayer was also pursuing the ...

About 4% to 10% of the adult population experiences chronic cough — a cough lasting eight weeks or more, or at least four weeks for children. A chronic cough doesn't call for immediate medical ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Data were derived from Gallagher TJ, et al. JAMA ...

Chronic bronchitis is diagnosed when you have an ongoing, productive cough. While it isn’t deadly, the severity of your chronic bronchitis can depend on your treatment and emergency care. Chronic ...